Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Bulletin Du Cancer|December 20, 2024
[Vaccination of children and adolescents treated for acute leukemia, excluding HSCT recipients: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)]Aphaia Roussel, Camille Léglise, Fanny Rialland, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2016
Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair AnalysisFlorence Rabian, Raphael Porcher, Flore Sicre de Fontbrune, et al.Bulletin Du Cancer|January 11, 2021
[Eligibility of patients for CAR T-cell: Expert opinion-based collaborative work by the SFGM-TC]David Beauvais, Emmanuel Bachy, André Baruchel, et al.Bulletin Du Cancer|July 21, 2022
[Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)]Paul Saultier, Mathieu Simonin, Tiphaine Adam de Beaumais, et al.Cancer Medicine|June 4, 2026
Descriptive Epidemiology and Prognosis of Pediatric Acute Leukemia in the Afro-Descendant Population of the French West Indies and French GuianaJulie Mascle, Andre Baruchel, Jacqueline Clavel, et al.Annals of Intensive Care|August 17, 2022
The use of ICU resources in CAR-T cell recipients: a hospital-wide studySandrine Valade, Michael Darmon, Lara Zafrani, et al.Haematologica|October 17, 2024
Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropeniaFlorent Puisset, Emmanuel Raffoux, Lionel Ades, et al.Hemasphere|July 23, 2026
Transplant versus no transplant outcome in adolescents and adults with sickle cell disease eligible for allogeneic hematopoietic stem cell transplantationCécile Pivert, Loïc Vasseur, Matthieu Jestin, et al.Leukemia|June 26, 2020
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapyMarco Cerrano, Matthieu Duchmann, Rathana Kim, et al.Hemasphere|July 19, 2026
Hemophagocytic lymphohistiocytosis-like syndrome after CD19-directed CAR T-cells for B-cell lymphoma and B-cell acute lymphoblastic leukemia: A LYSA, SFCE, and GRAALL study from the DESCAR-T registryNicolas Gower, Roch Houot, Cécile Pizot, et al.Pageof 3